• “Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-based Products: Minimal Manipulation and Homologous Use”

    On November 16, 2017, The FDA posted definitive guidelines concerning what meets minimal manipulation rules and regulations and what is accepted under the practice of medicine guidelines in the specialty of Regenerative Medicine. The FDA further restated the requirement that regenerative medicine be...

    Read More

  • My Algorithm If Stem Cell Intervention Doesn’t Last or Doesn’t Work

    My Algorithm If Stem Cell Intervention Doesn’t Last or Doesn’t Work

    I am being forthright; based on my review of data, while 80% or more of my patients continue to enjoy satisfactory outcomes at four years or more following a stem cell intervention, there are those whose symptoms and functional limitations recur. Please be aware that when I undertake the care and treatment...

    Read More

  • Exciting Cellular Orthopedic Debates

    Exciting Cellular Orthopedic Debates

    Well, it is really an internal debate as to whether I should have a concentrated platelet rich plasma procedure or a bone marrow concentrate procedure as I get ready for the upcoming ski season. While it is true that I exercise five to six days a week rotating between outdoor cycling, strength training...

    Read More

  • Ongoing happenings in Stem Cell Care of Arthritis

    Ongoing happenings in Stem Cell Care of Arthritis

    The number of options for regenerative medicine continues to multiply in metropolitan Chicago so the patient seeking the best alternative must remain ever vigilant. A two-day course basically allows anyone with a medical license to become an immediate “expert”. Incidentally, several of these national...

    Read More

  • “FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments”

    “FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments”

    The Food and Drug Administration is cracking down on “unscrupulous” clinics selling unproven and potentially dangerous treatments involving stem cells. Hundreds of clinics around the country have started selling stem cell therapies that supposedly use stem cells but have not been approved...

    Read More

  • Advancing the Discipline of Cellular Orthopedics

    Advancing the Discipline of Cellular Orthopedics

    Most readers know that I “graduated” from joint replacement surgery into an emerging field of Regenerative Medicine about five years ago. Prior to that time, I had dedicated 37 years to Reconstructive Orthopedic Surgery and played an active role in a joint replacement practice combining research...

    Read More

  • A Cellular Orthopedic Regenerative Testimonial

    A Cellular Orthopedic Regenerative Testimonial

    “Haven’t spoken with you in a few months so I thought you might be interested to hear about my knees since the January injections. Things are definitely better. The most important of which is my really bad left knee doesn’t lock up when I roll over in bed. It hurt so bad that it used

    Read More

  • Combining Bone Marrow Concentrate into the joint with Subchondroplasty

    Combining Bone Marrow Concentrate into the joint with Subchondroplasty

    We now are approaching five-year outcomes regarding the use of Bone Marrow Concentrate for Osteoarthritis of the hip, knee, shoulder and ankle. Bone Marrow contains Adult Mesenchymal Stem (MSC) cells and Growth Factors. In the beginning, the entire informed consent process focused on the MSC in bone...

    Read More

  • Postpone, perhaps avoid joint replacements

    Postpone, perhaps avoid joint replacements

    Last week, we traveled to Israel to celebrate the wedding of our youngest son. Israel became the destination for the event as Eric and Judith had met there while his music business was subcontracting to Coke and Judith led the International Marketing initiatives for Coke. The event took place on July...

    Read More

  • Regenerative options for patients receiving chemotherapy, immunosuppression or radiation therapy

    Regenerative options for patients receiving chemotherapy, immunosuppression or radiation therapy

    There has always been a category of patients for whom Bone Marrow Concentrate derived stem cells and growth factors were not a viable option. Patients who have received or are receiving chemotherapy, radiation therapy or immunosuppression have diminished stem cell viability and actual numbers. Such...

    Read More

Back to top